Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-28

FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)

View source ↗

Summary

The FDA approved a supplemental application for Claritin RediTabs containing loratadine, introducing a new dosage form under Bayer Healthcare LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claritin RediTabs (Loratadine)

Snippet

SUPPL AP for CLARITIN REDITABS (LORATADINE)